To be part of your patient’s life, they have to first be part of rigorous levels of clinical trials. Our quality and medical parameters bind us into continued state-of-the-art stents that offer lifelong health and wellness.
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale & design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus
Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: Six-month OCT follow-up from the TAXCO study.
Abstract Book 2018. PCROnline.com.
Optical Coherence Tomography Study
Comparison of biodegradable polymer (Everoflex) vs. permanent polymer (Xience Pro) coated everolimus-eluting coronary stent systems in all-comer patient population at a tertiary care hospital - One-year outcome study.
Safety and efficacy of ultra-thin biodegradable polymer-coated everolimus-eluting stent in real-world patients with coronary artery disease – One-year outcomes of Indian multi-centric ‘EVERsafe’ Study.
J Am Coll Cardiol. Vol. 70, No. 18, Suppl. B314-B315 (TCT-742), October 2017
Clinical experience after implantation of ultrathin strut biodegradable polymer-coated everolimus-eluting stents for treatment of atherosclerotic lesions: all-comer single-centre registry with a subgroup analysis of patients with ultra-long stents
Comparison of two biodegradable polymer coated, drug-eluting coronary stents paclitaxel vs. sirolimus, with 6-years clinical follow-up: BIOPRESS (BIOdegradable Polymer REgistry Smt Stents) Infinnium vs. Supralimus
Journal of Cardiology and Therapeutics. 2014;2(1):12-20.
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73.
Randomized Controlled Trial